Dysregulation of inflammasome activation in glioma
- PMID: 37723542
- PMCID: PMC10506313
- DOI: 10.1186/s12964-023-01255-5
Dysregulation of inflammasome activation in glioma
Abstract
Gliomas are the most common brain tumors characterized by complicated heterogeneity. The genetic, molecular, and histological pathology of gliomas is characterized by high neuro-inflammation. The inflammatory microenvironment in the central nervous system (CNS) has been closely linked with inflammasomes that control the inflammatory response and coordinate innate host defenses. Dysregulation of the inflammasome causes an abnormal inflammatory response, leading to carcinogenesis in glioma. Because of the clinical importance of the various physiological properties of the inflammasome in glioma, the inflammasome has been suggested as a promising treatment target for glioma management. Here, we summarize the current knowledge on the contribution of the inflammasomes in glioma and therapeutic insights. Video Abstract.
Keywords: Glioma; Inflammasome; Neuroinflammation; Therapeutic strategy.
© 2023. BioMed Central Ltd., part of Springer Nature.
Conflict of interest statement
The authors declare no competing interests.
Figures
Similar articles
-
Non-canonical NLRC4 inflammasomes in astrocytes contribute to glioma malignancy.Inflamm Res. 2023 Apr;72(4):813-827. doi: 10.1007/s00011-023-01710-6. Epub 2023 Mar 10. Inflamm Res. 2023. PMID: 36899084
-
Upregulation of the NLRC4 inflammasome contributes to poor prognosis in glioma patients.Sci Rep. 2019 May 27;9(1):7895. doi: 10.1038/s41598-019-44261-9. Sci Rep. 2019. PMID: 31133717 Free PMC article.
-
Aberrant expression of interleukin-1β and inflammasome activation in human malignant gliomas.PLoS One. 2014 Jul 23;9(7):e103432. doi: 10.1371/journal.pone.0103432. eCollection 2014. PLoS One. 2014. PMID: 25054228 Free PMC article.
-
Inflammasome Signaling: A Novel Paradigm of Hub Platform in Innate Immunity for Cancer Immunology and Immunotherapy.Front Immunol. 2021 Aug 5;12:710110. doi: 10.3389/fimmu.2021.710110. eCollection 2021. Front Immunol. 2021. PMID: 34421915 Free PMC article. Review.
-
Inflammasomes in cancer: Effect of epigenetic and autophagic modulations.Semin Cancer Biol. 2022 Aug;83:399-412. doi: 10.1016/j.semcancer.2020.09.013. Epub 2020 Oct 9. Semin Cancer Biol. 2022. PMID: 33039557 Review.
Cited by
-
The interaction of inflammasomes and gut microbiota: novel therapeutic insights.Cell Commun Signal. 2024 Apr 2;22(1):209. doi: 10.1186/s12964-024-01504-1. Cell Commun Signal. 2024. PMID: 38566180 Free PMC article. Review.
-
Pulsed focused ultrasound alters the proteomic profile of the tumor microenvironment in a syngeneic mouse model of glioblastoma.J Neurooncol. 2024 Nov;170(2):347-361. doi: 10.1007/s11060-024-04801-4. Epub 2024 Aug 24. J Neurooncol. 2024. PMID: 39180641
-
Blood-brain barrier permeability increases with the differentiation of glioblastoma cells in vitro.Fluids Barriers CNS. 2024 Nov 1;21(1):89. doi: 10.1186/s12987-024-00590-0. Fluids Barriers CNS. 2024. PMID: 39487455 Free PMC article.
-
Microglial- neuronal crosstalk in chronic viral infection through mTOR, SPP1/OPN and inflammasome pathway signaling.Front Immunol. 2024 Apr 5;15:1368465. doi: 10.3389/fimmu.2024.1368465. eCollection 2024. Front Immunol. 2024. PMID: 38646526 Free PMC article. Review.
-
Sphingolipid Signaling and Complement Activation in Glioblastoma: A Promising Avenue for Therapeutic Intervention.Biochem (Basel). 2024 Jun;4(2):126-143. doi: 10.3390/biochem4020007. Epub 2024 Jun 6. Biochem (Basel). 2024. PMID: 38894892 Free PMC article.
References
-
- Weller M, Wick W, Aldape K, et al. Glioma. Nature reviews Disease primers. Jul 16 2015;1:15017. 10.1038/nrdp.2015.17 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical